Medical Genomics - Šárka Pospíšilová
CEITEC MU CEITEC MU
Medical Genomics - Šárka Pospíšilová

Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 Mutations to Chemotherapy

BLOOD

Zemanova, J; Sebejova, L; Hylse, O; Paruch, K; Pavlova, S; Mayer, J; Pospisilova, S; Trbusek, M, 2012: Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 Mutations to Chemotherapy. BLOOD 120(21)

Research Groups:

CEITEC authors: